| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/27/2000 | WO2000003695A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 01/27/2000 | WO2000003693A1 Survivin, and peptides thereof, as an anti-cancer vaccine |
| 01/27/2000 | WO2000003691A1 Systems and methods for local delivery of an agent |
| 01/27/2000 | WO2000003683A2 Liposomal encapsulated nucleic acid-complexes |
| 01/27/2000 | WO2000003682A2 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal |
| 01/27/2000 | WO2000003680A2 Emollient esters based upon capryl alcohol and isostearic acid |
| 01/27/2000 | WO2000003677A2 Use of bisphosphonates in the treatment of vascular restenosis |
| 01/27/2000 | WO2000003660A1 Biodegradable compositions for the controlled release of encapsulated substances |
| 01/27/2000 | WO1999062856A3 Citric acid doped with alkaline or alkaline-earth ions |
| 01/27/2000 | WO1999057094A3 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 01/27/2000 | WO1999056734A3 Transdermal therapeutic system for the administration of candesartan |
| 01/27/2000 | WO1999017780A8 Dexamethasone gel |
| 01/27/2000 | WO1998046257A8 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 01/27/2000 | DE19932216A1 Micro and nano particles useful e.g. as carriers of medicines, and agrochemicals, absorbents for cosmetic purposes, and for separations and analysis. |
| 01/27/2000 | DE19918588A1 Piperidinverbindung Piperidine |
| 01/27/2000 | DE19918435A1 Coating or binding agent for medicaments, prepared using finely divided acrylic copolymer powder, used e.g. for taste-masking coatings or in transdermal delivery systems |
| 01/27/2000 | DE19833287A1 Production of crosslinked cationic polymers in powder form, e.g. useful as cosmetic or pharmaceutical additives, comprises polymerization in supercritical carbon dioxide |
| 01/27/2000 | DE19833177A1 Rapidly acting plaster preparation for treating irritation due to nettle stings or insect bites, preferably containing menthol and benzocaine |
| 01/27/2000 | DE19833119A1 Storage-stable injectable solution of vasodilator and beta blocker Carvedilol contains buffer, organic solvent, antioxidant and complexing agent |
| 01/27/2000 | DE19832519A1 Topical antiviral medicament for treating herpes infections, containing synergistic combination of adenosine and protein inhibiting antiviral agent, e.g. acyclovir |
| 01/27/2000 | CA2674800A1 Polymorph of a pharmaceutical |
| 01/27/2000 | CA2631050A1 Procedures for obtaining polymers derived from vinyl acetate and their use |
| 01/27/2000 | CA2338038A1 Process for obtaining polymers derived from vinyl acetate, and their uses |
| 01/27/2000 | CA2337516A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | CA2337499A1 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 01/27/2000 | CA2337445A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 01/27/2000 | CA2334811A1 Oxazolidinones to treat eye infections |
| 01/27/2000 | CA2303946A1 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal |
| 01/27/2000 | CA2303786A1 Freeze-dried product and method for preparing the same |
| 01/27/2000 | CA2302735A1 Microdisperse drug delivery systems |
| 01/26/2000 | EP0974366A1 Oral pharmaceutical preparations decreased in bitterness by masking |
| 01/26/2000 | EP0974365A1 Use of an acrylic-type polymer as desintregrating agent |
| 01/26/2000 | EP0974364A1 Method of inhibiting drug precipitation |
| 01/26/2000 | EP0974356A1 Tablets comprising a combination of metformin and glibenclamide |
| 01/26/2000 | EP0974355A1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same |
| 01/26/2000 | EP0974350A1 External preparation containing tranilast and process for producing the same |
| 01/26/2000 | EP0974346A2 Self-sealing capsule and method of producing same |
| 01/26/2000 | EP0974345A2 Capsule sealing system |
| 01/26/2000 | EP0974344A2 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 01/26/2000 | EP0974343A1 Metoprolol composition and processes for manufacturing the same |
| 01/26/2000 | EP0974332A1 Process for producing cosmetic and pharmaceutical formulations, and products comprising same |
| 01/26/2000 | EP0974320A1 Medical device for dispensing viscoelastic compositions |
| 01/26/2000 | EP0973878A1 Controlled dissolution cross-linked protein crystals |
| 01/26/2000 | EP0973818A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 01/26/2000 | EP0973605A1 Heat resistant lipid vesicles |
| 01/26/2000 | EP0973559A1 Method and composition for coating wound or protecting animal skin |
| 01/26/2000 | EP0973551A2 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/26/2000 | EP0973529A2 Essential oil composition |
| 01/26/2000 | EP0973527A1 Extended release formulations of erythromycin derivatives |
| 01/26/2000 | EP0973525A1 Oral compositions containing fluocinonide |
| 01/26/2000 | EP0973522A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 01/26/2000 | EP0973520A1 Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | EP0973510A1 Use of amantadine for treatment of hepatitis c |
| 01/26/2000 | EP0973509A1 Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same |
| 01/26/2000 | EP0973508A1 Pharmaceutical tablet of amiodarone salt |
| 01/26/2000 | EP0973507A1 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| 01/26/2000 | EP0973505A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/26/2000 | EP0973504A1 Hemostatic aerosol composition |
| 01/26/2000 | EP0973503A2 Non-aqueous compositions for oral administration |
| 01/26/2000 | EP0973502A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 01/26/2000 | EP0973501A2 Aqueous suspension for nasal administration of loteprednol |
| 01/26/2000 | EP0973500A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
| 01/26/2000 | EP0973499A1 Diffusional implantable delivery system |
| 01/26/2000 | EP0973498A1 Gastrointestinal mucosa-adherent pharmaceutical composition |
| 01/26/2000 | EP0973497A1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/26/2000 | EP0973485A2 Cosmetic and dermatological agent with a hard-magnetic particle base |
| 01/26/2000 | EP0973484A1 Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin |
| 01/26/2000 | EP0973461A1 Method of treatment of migraine |
| 01/26/2000 | EP0891202A4 Adhesive compositions including polyvinylpyrrolidone, acrylic acid polymers, and polyamines |
| 01/26/2000 | EP0763016B1 Compositions and methods for treating mast-cell mediated conditions |
| 01/26/2000 | EP0758895B1 Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
| 01/26/2000 | EP0722316B1 New emulsion formulation |
| 01/26/2000 | EP0695173B1 Manufacturing matrices |
| 01/26/2000 | EP0626943B1 Bistriazenes as chemotherapeutic agents |
| 01/26/2000 | CN1242752A Package of sheet-type patches |
| 01/26/2000 | CN1242705A Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | CN1242704A Tabletted prepn. |
| 01/26/2000 | CN1242703A Chewing gum contg. colloidal bismuth subcitrate |
| 01/26/2000 | CN1242702A Method and compositions for improved bioavailability of bioactive agent for mucosal delivery |
| 01/26/2000 | CN1242237A Dietetic food composition and dietetic method using such composition |
| 01/26/2000 | CN1242234A Method for preparing traditional Chinese medicine for calculuse diseases |
| 01/26/2000 | CN1242229A Navel plaster for treating stomach diseases |
| 01/26/2000 | CN1242225A Tibetan pill for treating cholecystitis and gallstones, and method for preparing same |
| 01/26/2000 | CN1242222A Adhesive medicine paster for treating anemia |
| 01/26/2000 | CN1242221A Active royal jelly sucked tablet and method for preparing same |
| 01/26/2000 | CN1242220A Medicine for treating nasal polyp |
| 01/26/2000 | CN1242219A Traditional Chinese medicine soft extract with bee honey for removing dust from lungs |
| 01/26/2000 | CN1242217A Traditional Chinese medicine compositions contg. pueraria root extract |
| 01/26/2000 | CN1242209A Traditonal Chinese medicine soft extract for anticancer and relieving pain |
| 01/26/2000 | CN1242204A Traditional Chinese medicine strengthening kidney soft extract |
| 01/26/2000 | CN1242200A Prepn. for treating rhinallergosis, and method for preparing same |
| 01/26/2000 | CN1242199A Process for producing powder injection of compound red sage root medicine |
| 01/26/2000 | CN1242197A Microencapsulated bovine adrenal medulla chromaffincell medicine used for treating Parkinson's disease |
| 01/26/2000 | CN1242193A Vaginal effervescent-tablets contg. azithromycin |
| 01/26/2000 | CN1048730C Zinc pipemidic, process for synthesizing same, and ointment contg. same |
| 01/26/2000 | CN1048640C External-use salve for treatment of pyemia |
| 01/26/2000 | CN1048639C Capsule for addition-eliminating and body strengthening function |
| 01/26/2000 | CN1048628C Prepn. of cyclopropyloxacini injection |
| 01/26/2000 | CN1048627C Medicinal aerosol prepn. |